Clinical Trials List
2005-11-01 - 2008-01-01
Phase III
Terminated3
ICD-10C79.51
Secondary malignant neoplasm of bone
ICD-10C79.52
Secondary malignant neoplasm of bone marrow
ICD-10C7B.03
Secondary carcinoid tumors of bone
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9198.5
Secondary malignant neoplasm of bone and bone marrow
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Terminated
The Actual Total Number of Participants Enrolled
0 Terminated
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
22 participants
-
Global
4577 participants
